The B-36 Peacemaker was more than just another bomber in a long line of bombers. It was conceived to fight an enemy—the Nazis ...

Blueprint Medicines (BPMC) shares ended the last trading session 18.2% higher at $103.36. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

In today’s global economy, industrial companies drive innovation, job creation and economic transformation. For rural ...

Barclays analyst Peter Lawson maintained a Hold rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of $105.00.

Drawing from three decades of frontline experience and scholarly research, Ron Tiffen’s groundbreaking new book “Disability ...

Gov. Laura Kelly looks back on the roster of bipartisan tax, education, child welfare, worker compensation and other policy ...

If you’ve recently received an Interac e-transfer for $36.29 from MNP, it’s part of the settlement for ... violating privacy laws in B.C., Saskatchewan, Manitoba, and Newfoundland and Labrador. The ...